The use of guidelines to assess the risk of malignant hyperthermia in individuals with an RYR1 variant.

Voermans, N C; Yang, C; Schouten, M; Girard, T; Stowell, K; Riazi, S; Kamsteeg, E J; Snoeck, M

Voermans, N C; Yang, C; Schouten, M; Girard, T; Stowell, K; Riazi, S; Kamsteeg, E J; Snoeck, M.

Affiliation

Voermans NC; Neuromuscular Center Nijmegen, Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Center, The Netherlands.
Yang C; Malignant Hyperthermia Investigation Unit, Department of Anesthesiology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Schouten M; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands.
Girard T; Clinic for Anaesthesia and Malignant Hyperthermie Investigation Unit, University Hospital Basel, Basel, Switzerland.
Stowell K; School of Natural Sciences, Massey University, Palmerston North, New Zealand.
Riazi S; Department of Anesthesia, Malignant Hyperthermia Investigation Unit, University Health Network, University of Toronto, Toronto, Canada.
Kamsteeg EJ; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands.
Snoeck M; Malignant Hyperthermia Investigation Unit, Department of Anesthesiology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands. Electronic address: m.snoeck@cwz.nl.

Neuromuscul Disord ; 35: 40-41, 2024 Feb.

Article in En | MEDLINE | ID: mdl-38007345

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Malignant Hyperthermia Limits: Humans Language: En Journal: Neuromuscul Disord Journal subject: NEUROLOGIA Year: 2024 Document type: Article Affiliation country:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google